نتائج البحث - "Uldrick TS"

المصدر: Uldrick, TS, A Mosam, F Shaik, G Friedland, D Skadden, JP Jordaan, J Aboobaker, and HM Coovadia. 2009. “Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770.” Infectious Agents and Cancer 4 (Suppl 2): P41. doi:10.1186/1750-9378-4-S2-P41. http://dx.doi.org/10.1186/1750-9378-4-S2-P41.

Relation: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261824/pdf/; Infectious Agents and Cancer

URL الوصول: http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581179

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

6

دورية أكاديمية

Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance.

المؤلفون: Marshall VA; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Cornejo Castro EM; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Goodman CA; Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Labo N; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Liu I; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Fisher NC; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Moore KN; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Nair A; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Immonen T; Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Keele BF; Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Mu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Saswat T; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Krug LT; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Lurain K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Ramaswami R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.

المصدر: PLoS pathogens [PLoS Pathog] 2024 Jul 15; Vol. 20 (7), pp. e1012338. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

مواضيع طبية MeSH: Herpesvirus 8, Human*/genetics , Sarcoma, Kaposi*/virology , Sarcoma, Kaposi*/genetics , Genome, Viral*, Humans ; Male ; Female ; Middle Aged ; Adult ; Polymorphism, Genetic ; Aged ; Herpesviridae Infections/genetics ; Herpesviridae Infections/virology ; Ethnicity/genetics ; Castleman Disease/virology ; Castleman Disease/genetics ; Phylogeny

Find this article in full text from ProQuest

Full Text Finder

7

دورية أكاديمية

Reflecting the Real World of Cancer Care - The Impact of Broadening Trial Eligibility.

المؤلفون: Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Uldrick TS; Fred Hutchinson Cancer Center, Seattle.

المصدر: NEJM evidence [NEJM Evid] 2024 Apr; Vol. 3 (4), pp. EVIDe2400011. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article; Editorial; Comment

بيانات الدورية: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Neoplasms*/epidemiology , Clinical Trials as Topic*, Humans ; Patient Selection ; Eligibility Determination

8

تقرير

Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma.

المؤلفون: Anidi IU; Critical Care Medicine and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Sakai S; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Brooks K; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fling SP; Cancer Immunotherapy Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Wagner MJ; Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California, USA., Knox KS; Department of Internal Medicine, College of Medicine Phoenix, University of Arizona Health Sciences, Phoenix, Arizona, USA., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Uldrick TS; Cancer Immunotherapy Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sharon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Barber DL; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2024 Mar 31; Vol. 11 (5), pp. ofae183. Date of Electronic Publication: 2024 Mar 31 (Print Publication: 2024).

نوع المنشور: Clinical Trial

بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Full Text Finder

9

Editorial & Opinion

Remission after rituximab for HHV8+ MCD: what next?

المؤلفون: Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Uldrick TS; Oncology, Fred Hutchinson Cancer Center, Seattle, WA.

المصدر: Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5661-5662.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Castleman Disease* , HIV Infections*, Humans ; Rituximab/therapeutic use

SCR Disease Name: Multi-centric Castleman's Disease

Full Text via ClinicalKey

Full Text Finder

10

دورية أكاديمية

Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis.

المؤلفون: Ramaswami R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Tagawa T; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Mahesh G; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Serquina A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Koparde V; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lurain K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Dremel S; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Li X; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Mungale A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Beran A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ohler ZW; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Bassel L; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Warner A; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mangusan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Widell A; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ekwede I; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Krug LT; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ziegelbauer JM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, 20892, USA. ziegelbauerjm@nih.gov.

المصدر: Journal of translational medicine [J Transl Med] 2023 Sep 22; Vol. 21 (1), pp. 653. Date of Electronic Publication: 2023 Sep 22.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma, Kaposi*/genetics , Herpesvirus 8, Human*/genetics , Skin Neoplasms*, Humans ; Endothelial Cells ; Skin ; Interleukin-6

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

تنقيح النتائج